Effective treatment for lithium pilocarpine-induced status epilepticus: clonazepam and lacosamide combination
Epilepsy & Behavior · 2026-09 · 182 · 111092
DOI: 10.1016/j.yebeh.2026.111092 ↗Kurz gefasst
Fachartikel in der Zeitschrift Epilepsy & Behavior, 2026-09. Verfasst von Cumaali Demirtas und 5 weiteren Autor:innen. Beteiligte Einrichtung: Hamidiye Institute of Health Sciences, University of Health Sciences, Istanbul, Turkiye. Electronic address: cumaali.demirtas@sbu.edu.tr. Hauptthemen laut MEDLINE: Status Epilepticus, Anticonvulsants, Clonazepam, Acetamides. Die Arbeit nennt 60 Literaturangaben.
Abstract (Originalsprache)
This study aimed to investigate the potential of clonazepam (CLZ), one of the benzodiazepines used in the first-line treatment of status epilepticus, in combination with anti-seizure medications such as levetiracetam (LEV), lacosamide (LCM), valproic acid (VPA), and fosphenytoin (fPHT), which are used in second-line treatment, in polytherapy. Fifty-six male Sprague-Dawley rats were randomly assigned to seven groups. A status epilepticus model was induced by injection of lithium Cl (5 mEq/kg, s.c.) and pilocarpine HCl (320 mg/kg, i.p.). After induction of status epilepticus, CLZ (1 mg/kg) was administered either alone or in combination with LEV (200 mg/kg), LCM (50 mg/kg), VPA (300 mg/kg), and fPHT (100 mg/kg). Video-EEG recordings were taken from the animals, and behavioral tests were performed. Mortality rates were significantly lower in the CLZ + LCM, CLZ + VPA, and CLZ + fPHT groups compared to the status epilepticus group (p < 0.01, p < 0.05, p < 0.01, respectively), and in the CLZ + LCM and CLZ + fPHT groups compared to CLZ monotherapy (p < 0.05). Spike frequency decreased in all combination groups (p < 0.01). Spike amplitude decreased in the CLZ + LCM and CLZ + VPA combinations (p < 0.01, p < 0.05, respectively). Anxiety levels increased in the CLZ + LCM and CLZ + VPA groups (p < 0.05). Performance impairment related to spatial memory was observed in the CLZ + fPHT group (p < 0.05). A decrease in forced motor functions was observed in the CLZ + VPA and CLZ + fPHT groups compared to the control group (p < 0.01). In conclusion, CLZ alone and the CLZ-LEV combination were insufficient to prevent epileptiform activity associated with status epilepticus, whereas CLZ-based polytherapies -most notably CLZ-LCM, followed by CLZ-VPA and CLZ-fPHT- were more effective in reducing epileptiform spike frequency and amplitude.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hamidiye Institute of Health Sciences, University of Health Sciences, Istanbul, Turkiye. Electronic address: cumaali.demirtas@sbu.edu.tr.
- Department of Physiology, Faculty of Medicine, Tokat Gaziosmanpasa University, Tokat, Turkiye.
- Department of Physiology, Hamidiye Faculty of Medicine, University of Health Sciences, Istanbul, Turkiye.
- Department of Physiology, Hamidiye Institute of Health Sciences, University of Health Sciences, Istanbul, Turkiye.
- Department of Medical Biology, Hamidiye Institute of Health Sciences, University of Health Sciences, Istanbul, Turkiye.
- Department of Physiology, Hamidiye Faculty of Medicine, University of Health Sciences, Istanbul, Turkiye. Electronic address: mehmet.yildirim@sbu.edu.tr.
Zitieren
APA
Demirtas, C., Akca, M., Aykin, U., Surmeneli, Y. E., Yildirim, H., & Yildirim, M. (2026). Effective treatment for lithium pilocarpine-induced status epilepticus: clonazepam and lacosamide combination. Epilepsy & Behavior, 182, 111092. https://doi.org/10.1016/j.yebeh.2026.111092
Vancouver
Demirtas C, Akca M, Aykin U, Surmeneli YE, Yildirim H, Yildirim M. Effective treatment for lithium pilocarpine-induced status epilepticus: clonazepam and lacosamide combination. Epilepsy & Behavior. 2026;182:111092. doi:10.1016/j.yebeh.2026.111092
BibTeX
@article{Demirtas2026,
author = {Demirtas, Cumaali and Akca, Metehan and Aykin, Ugur and Surmeneli, Yunus Emre and Yildirim, Hava and Yildirim, Mehmet},
title = {Effective treatment for lithium pilocarpine-induced status epilepticus: clonazepam and lacosamide combination},
journal = {Epilepsy & Behavior},
year = {2026},
volume = {182},
pages = {111092},
doi = {10.1016/j.yebeh.2026.111092}
}
EUVIMED